Moderate

Primary amenorrhoea

Primary amenorrhoea · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Primary amenorrhoea is absence of menarche by age 15 with normal secondary sexual characteristics, or by age 13 with none. Evaluation distinguishes outflow tract, gonadal, pituitary and hypothalamic causes.

Red flags

  • Cyclical pelvic pain with absent menses (obstructed outflow/haematocolpos)
  • Short stature with features of Turner syndrome
  • Signs of virilisation
  • Absent uterus (androgen insensitivity or Mullerian agenesis)
  • Anosmia (Kallmann syndrome)

Assessment

Differential diagnosis

  • Constitutional delay
  • Turner syndrome (gonadal dysgenesis)
  • Androgen insensitivity syndrome
  • Mullerian agenesis (MRKH)
  • Imperforate hymen/outflow obstruction
  • Hypothalamic/pituitary causes
  • Congenital adrenal hyperplasia

Investigations

  • Assessment of secondary sexual characteristics and growth
  • Pelvic ultrasound for presence of uterus and ovaries
  • FSH, LH and oestradiol
  • Karyotype where gonadal dysgenesis or androgen insensitivity suspected
  • Prolactin, TSH and testosterone
  • Examination for outflow obstruction (e.g. imperforate hymen)

Management

  • Take a history of growth, pubertal development, and family history of late menarche
  • Examine for secondary sexual characteristics and signs of outflow obstruction
  • Arrange pelvic ultrasound to confirm the presence of a uterus
  • Measure gonadotrophins to separate hypergonadotrophic (ovarian) from hypogonadotrophic (central) causes
  • Perform karyotyping where indicated (e.g. short stature, absent uterus with normal breasts)
  • Relieve outflow obstruction surgically (e.g. imperforate hymen)
  • Treat the underlying cause and induce puberty with oestrogen where gonadal failure is present
  • Provide hormone replacement and bone-health measures for hypogonadism
  • Offer psychological support and fertility counselling as appropriate

Drugs & doses

Low-dose oestrogen (e.g. estradiol) to induce puberty, gradually increased
Add cyclical progestogen once breakthrough bleeding or adequate oestrogenisation occurs
Combined hormonal preparation for maintenance hormone replacement
Treat specific endocrine causes (e.g. hydrocortisone in congenital adrenal hyperplasia)

Disposition

Refer to paediatric and adolescent gynaecology and endocrinology; involve specialist multidisciplinary teams for intersex conditions and syndromic causes.

Complications & pitfalls

  • Osteoporosis from untreated hypogonadism
  • Psychological impact
  • Infertility
  • Complications of underlying syndrome (e.g. cardiac/renal in Turner)
  • Gonadal malignancy risk in some intersex conditions

Exam pearls

  • Pelvic ultrasound to confirm a uterus is an efficient early discriminator
  • High FSH points to ovarian failure; low or normal FSH points to a central cause
  • Cyclical pain with primary amenorrhoea suggests outflow obstruction needing surgery
  • Androgen insensitivity presents with female phenotype, absent uterus and a 46,XY karyotype

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.